By covering somatic mutations, indels, copy-number alterations, gene fusions, gene expression, and outlier expression, we demonstrate that a majority of MM patients harbor alterations in the NF-κB and RAS-MAPK pathways; this is a level of prevalence that has not been previously reported and includes many alterations with diverse mechanisms of action. Here, NFKB1 is linked to Miyoshi myopathy.